FTSE 100
10.446,35
PKT
+43,91
PKT
+0,42
%
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.01.26 | Rolls-Royce Buy | UBS AG | |
| 09.01.26 | Unilever Sell | UBS AG | |
| 09.01.26 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 09.01.26 | Rio Tinto Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.01.26 | National Grid Overweight | Barclays Capital | |
| 09.01.26 | Glencore Outperform | RBC Capital Markets | |
| 09.01.26 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 08.01.26 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | GSK Hold | Deutsche Bank AG | |
| 08.01.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 08.01.26 | HSBC Sector Perform | RBC Capital Markets | |
| 08.01.26 | Rio Tinto Hold | Deutsche Bank AG | |
| 08.01.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 08.01.26 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 08.01.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 08.01.26 | BP Hold | Jefferies & Company Inc. | |
| 07.01.26 | International Consolidated Airlines Equal Weight | Barclays Capital | |
| 07.01.26 | RELX Overweight | JP Morgan Chase & Co. | |
| 07.01.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 07.01.26 | Diageo Neutral | UBS AG | |
| 07.01.26 | GSK Buy | Jefferies & Company Inc. | |
| 07.01.26 | Unilever Outperform | Bernstein Research | |
| 07.01.26 | GSK Underweight | Barclays Capital | |
| 07.01.26 | Vodafone Group Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.26 | Diageo Hold | Deutsche Bank AG | |
| 06.01.26 | easyJet Outperform | Bernstein Research | |
| 06.01.26 | International Consolidated Airlines Outperform | Bernstein Research | |
| 06.01.26 | BP Sector Perform | RBC Capital Markets | |
| 06.01.26 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 06.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.01.26 | BP Neutral | UBS AG | |
| 06.01.26 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 06.01.26 | Rolls-Royce Market-Perform | Bernstein Research | |
| 06.01.26 | Diageo Outperform | RBC Capital Markets | |
| 05.01.26 | Vodafone Group Sell | UBS AG | |
| 05.01.26 | easyJet Underweight | JP Morgan Chase & Co. | |
| 02.01.26 | Rolls-Royce Buy | Jefferies & Company Inc. | |
| 30.12.25 | Unilever Overweight | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.